Literature DB >> 8166142

Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV.

C Behrendt1, N Kendig, C Dambita, J Horman, J Lawlor, D Vlahov.   

Abstract

This study evaluated voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high HIV seroprevalence. Data on demographic variables and participation in voluntary testing were linked to a blinded HIV serosurvey of consecutive Maryland prison entrants (April-July 1991). Among 2,842 entrants, HIV seroprevalence was 8.5% (men, 7.9%; women, 15.3%). Voluntary testing was accepted by 47% of the entrants, and it identified 34% of the HIV-seropositive inmates detected by serosurvey. Refusers of testing were more likely to test HIV-seropositive than were accepters (adjusted odds ratio (OR) = 1.84, 95% confidence interval (CI) 1.58-2.16). Refusers and accepters of testing had similar risk factors for HIV infection, chiefly current syphilis infection (adjusted OR = 5.96, 95% CI 3.15-10.27) and prior injected drug use (adjusted OR = 4.26, 95% CI 3.15-5.76). Among 100 entrants asked why they refused testing, primary reasons given included low risk of HIV, fear of testing HIV-seropositive, and lack of interest. Voluntary testing appears only moderately successful in identifying HIV-seropositive inmates in a high-seroprevalence prison population. However, the alternative, mandatory HIV testing of prisoners, can be construed as discriminatory and unethical when similar screening is not imposed on the population at large. Data presented here suggest strategies to improve acceptance of voluntary testing, especially by high risk inmates.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  1994        PMID: 8166142     DOI: 10.1093/oxfordjournals.aje.a117098

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  28 in total

1.  Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.

Authors:  Grace E Macalino; David Vlahov; Stephanie Sanford-Colby; Sarju Patel; Keith Sabin; Christopher Salas; Josiah D Rich
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

2.  Disease prevalence and use of health care among a national sample of black and white male state prisoners.

Authors:  David L Rosen; Wizdom P Hammond; David A Wohl; Carol E Golin
Journal:  J Health Care Poor Underserved       Date:  2012-02

3.  From corrections to communities as an HIV priority.

Authors:  David Vlahov; Sara Putnam
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

4.  Young incarcerated men's perceptions of and experiences with HIV testing.

Authors:  Deborah Kacanek; Gloria D Eldridge; Jill Nealey-Moore; Robin J MacGowan; Diane Binson; Timothy P Flanigan; Christine C Fitzgerald; James M Sosman
Journal:  Am J Public Health       Date:  2007-05-30       Impact factor: 9.308

Review 5.  The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis.

Authors:  Princess A Iroh; Helen Mayo; Ank E Nijhawan
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

6.  The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997.

Authors:  Theodore M Hammett; Mary Patricia Harmon; William Rhodes
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

7.  Profile of HIV seropositive inmates diagnosed in Maryland's state correctional system.

Authors:  N Kendig; T Stough; P Austin; L Kummer; A Swetz; D Vlahov
Journal:  Public Health Rep       Date:  1994 Nov-Dec       Impact factor: 2.792

Review 8.  HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care.

Authors:  Ryan P Westergaard; Anne C Spaulding; Timothy P Flanigan
Journal:  Curr Opin Infect Dis       Date:  2013-02       Impact factor: 4.915

9.  Establishment of an HIV/sexually transmitted disease programme and prevalence of infection among incarcerated men in Jamaica.

Authors:  K Andrinopoulos; D Kerrigan; J P Figueroa; R Reese; C A Gaydos; L Bennett; B Bloomfield; L Plunkett; C Maru; J M Ellen
Journal:  Int J STD AIDS       Date:  2010-02       Impact factor: 1.359

10.  HIV and hepatitis C virus testing and seropositivity rates in Canadian federal penitentiaries: A critical opportunity for care and prevention.

Authors:  Prithwish De; Nancy Connor; Françoise Bouchard; Donald Sutherland
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-07       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.